China Pharma Holdings PE Ratio 2010-2023 | CPHI

Current and historical p/e ratio for China Pharma Holdings (CPHI) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. China Pharma Holdings PE ratio as of April 18, 2024 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

China Pharma Holdings PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-04-19 0.32 0.00
2023-12-31 0.61 $-0.90 0.00
2023-09-30 0.74 $-0.90 0.00
2023-06-30 1.71 $-1.60 0.00
2023-03-31 1.95 $-2.30 0.00
2022-12-31 4.80 $-3.00 0.00
2022-09-30 6.50 $-4.00 0.00
2022-06-30 10.73 $-4.00 0.00
2022-03-31 19.50 $-4.00 0.00
2021-12-31 24.13 $-4.00 0.00
2021-09-30 27.93 $-4.50 0.00
2021-06-30 36.16 $-3.50 0.00
2021-03-31 42.00 $-3.50 0.00
2020-12-31 22.29 $-24.00 0.00
2020-06-30 33.32 $-23.50 0.00
2020-03-31 25.20 $-24.50 0.00
2019-12-31 11.84 $-24.00 0.00
2019-09-30 12.26 $-3.50 0.00
2019-06-30 16.17 $-11.00 0.00
2019-03-31 16.59 $-12.00 0.00
2020-09-30 18.24 $-12.50 0.00
2018-12-31 12.87 $-12.00 0.00
2018-09-30 10.21 $-19.50 0.00
2018-06-30 11.00 $-20.00 0.00
2018-03-31 15.86 $-21.50 0.00
2017-12-31 8.78 $-22.00 0.00
2017-09-30 8.75 $-10.00 0.00
2017-06-30 11.50 $-9.50 0.00
2017-03-31 13.00 $-10.00 0.00
2016-12-31 13.00 $-8.00 0.00
2016-09-30 10.75 $-9.00 0.00
2016-06-30 12.00 $-11.50 0.00
2015-12-31 7.85 $-17.50 0.00
2015-09-30 9.92 $-28.50 0.00
2015-06-30 18.00 $-25.50 0.00
2015-03-31 17.00 $-28.50 0.00
2014-12-31 15.01 $-29.50 0.00
2016-03-31 8.50 $-22.00 0.00
2014-09-30 12.55 $-32.00 0.00
2014-06-30 19.25 $-27.00 0.00
2014-03-31 25.25 $-22.00 0.00
2013-12-31 17.25 $-22.50 0.00
2013-09-30 14.00 $-11.50 0.00
2013-06-30 10.50 $-7.50 0.00
2013-03-31 14.50 $-0.50 0.00
2012-12-31 10.10 $5.50 1.84
2012-09-30 18.25 $13.00 1.40
2012-06-30 17.00 $15.50 1.10
2012-03-31 34.00 $19.50 1.74
2011-12-31 33.50 $22.50 1.49
2011-09-30 48.50 $25.50 1.90
2011-06-30 112.50 $28.00 4.02
2011-03-31 126.50 $28.00 4.52
2010-12-31 151.50 $27.00 5.61
2010-09-30 124.50 $23.50 5.30
2010-06-30 137.50 $25.50 5.39
2010-03-31 166.50 $24.50 6.80
2009-12-31 192.50 $24.00 8.02
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.005B $0.007B
CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $14.328B 5.17
Dr Reddy's Laboratories (RDY) India $11.833B 18.71
Aspen Pharmacare (APNHY) South Africa $5.172B 0.00
BridgeBio Pharma (BBIO) United States $4.387B 0.00
Bausch Health Cos (BHC) Canada $3.143B 2.45
Amphastar Pharmaceuticals (AMPH) United States $1.889B 12.93
Supernus Pharmaceuticals (SUPN) United States $1.580B 0.00
Taysha Gene Therapies (TSHA) United States $0.451B 0.00
Generation Bio (GBIO) United States $0.185B 0.00
Assembly Biosciences (ASMB) United States $0.073B 0.00
Personalis (PSNL) United States $0.061B 0.00
Acasti Pharma (ACST) Canada $0.029B 0.00
Sol-Gel Technologies (SLGL) Israel $0.025B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00